Obesity Medication

BMI 35 or more, without Type 2 Diabetes

Locations: Long Island City, Queens (36-36 33rd Street)

Cost to you: none for study visits, tests, or study medication

Questions: 516-574-9232 · Hablamos español

A Phase 3 study investigating the efficacy and safety of an investigational medication in adults with obesity who do not have Type 2 diabetes.
- At least 18 years of age
- Stable self-reported body weight (less than 5% change) for the 90 days before screening
- BMI of 35 or more at screening
- At least one self-reported unsuccessful attempt to lose weight through diet
Gain access to cutting-edge medications and treatments before they are widely available.
Our expert team is under the guidance of renowned endocrinologist, Dr. Anastasios Manessis.
We are highly focused on patient well-being and the highest ethical standards in clinical research.